December 3, 2016

CATAWBA RESEARCH INTRODUCES NEW SERIES OF TRAINING VIDEOS

The quest for consistency in subjective clinical assessments, has led to the development of a number of grading methods to achieve data reliability. Whether it is the IGA, PASI, PGA or signs and symptoms scale to assess severity, the inherent nature of the subjective assessments still plays a role in impacting good reproducible and robust data.

At Catawba Research, we are acutely aware of these challenges, and as such, we are working with industry leaders to develop tools to provide us with consistency and reproducible data. Ultimately, excellent data is what our clients and the regulatory agencies strive to achieve.

Here at Catawba Research, one of the things we get most excited about is continually improving processes and finding new ways to approach clinical research. We like to think outside the box and develop new methods to improve the overall quality and outcome of our clients’ clinical trials.

We are pleased to announce the arrival of our latest brainchild – training videos! We have been hard at work developing and filming a series of comprehensive, indication and product-specific training videos for the individual therapeutic areas we’re conducting trials in. Each video is extensive, with more than 30 minutes of technical information specific to that indication or product, as explained by a key opinion leader in the industry. Following the deep dive into the indication or product, trainees will get to take part in a brief test to aid in retention of the topic.

These videos are intended for the key study team members involved in the clinical trial. This initiative is part of a comprehensive approach to training, as CRAs and investigator sites will receive this training on top of their standard therapeutic and protocol training. The overall goal of these video lessons is to improve consistency, reduce variably, and yield more robust data. We are confident this innovative approach to training is something that will greatly benefit all parties involved and improve the outcome of our clients’ programs.

Catawba Research is committed to being a pioneer in our therapeutic areas of focus, which include dermatology , women’s health , and ophthalmic clinical trials . These new, state of the art training videos are the result of months of hard work, and we couldn’t be more pleased with the end product. We look forward to future iterations and continuing to find new ways to add value to your clinical programs.

To learn more about our training program or see some our videos, contact us !

Won’t you get hip to this kindly tip, get your kicks on Route 505(b)(2). What is that?Route 505(b)(2) vs. 505(j)Altasciences Acquires WCCT Global“ This acquisition is an integral part of Altasciences’ strategic growth plan to provide a comprehensive, fully integrated early phase drug development solution to address the ever-changing outsourcing challenges of biopAn Overview of GDUFAThe Office of Generic Drugs (OGD) reports directly to the Director of the Center for Drug Evaluation and Research (CDER). The OGD’s mission is to ensure safe, effective, and affordable medicines for the American public.Catawba Research Concludes Another Rosacea Clinical TrialCatawba Research is pleased to announce another achievement for a recently completed rosacea clinical trial. In this trial, Catawba enrolled more than 1000 rosacea subjects in 22 weeks from 33 sites .Catawba Research Achieves Acne First-to-FileThe team at Catawba Research has recently completed a first-to-file submission for acne clinical trial . In this study, Catawba enrolled a staggering 1125 acne vulgaris subjects in 8 weeks from 12 sites .Catawba Research Adds Tinea Pedis Video to Training LibraryTo learn more about our training program or see some our videos, contact us !